These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12109461)

  • 1. [Vasovagal syncope and beta-blockers].
    Anadolu Kardiyol Derg; 2001 Jun; 1(2):109. PubMed ID: 12109461
    [No Abstract]   [Full Text] [Related]  

  • 2. beta-adrenergic receptor blockers and the treatment of vasovagal syncope: more nails in the coffin!
    Mathias CJ
    Clin Sci (Lond); 2006 Sep; 111(3):189-91. PubMed ID: 16848762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent effect of β-blockers in preventing vasovagal syncope.
    Sheldon RS; Morillo CA; Klingenheben T; Krahn AD; Sheldon A; Rose MS
    Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):920-6. PubMed ID: 22972872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope.
    Sheldon R; Connolly S; Rose S; Klingenheben T; Krahn A; Morillo C; Talajic M; Ku T; Fouad-Tarazi F; Ritchie D; Koshman ML;
    Circulation; 2006 Mar; 113(9):1164-70. PubMed ID: 16505178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second Vasovagal Pacemaker Study (VPS II): rationale, design, results, and implications for practice and future clinical trials.
    Sheldon R; Connolly S;
    Card Electrophysiol Rev; 2003 Dec; 7(4):411-5. PubMed ID: 15071266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Syncope Trial (POST): a randomized clinical trial of beta blockers in the prevention of vasovagal syncope; rationale and study design.
    Sheldon R; Rose S; Connolly S
    Europace; 2003 Jan; 5(1):71-5. PubMed ID: 12504644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockers in syncope: the jury is still out.
    Sheldon RS; Raj SR; Rose S; Connolly SJ
    J Am Coll Cardiol; 2001 Dec; 38(7):2135-6. PubMed ID: 11738330
    [No Abstract]   [Full Text] [Related]  

  • 8. Predicting the effectiveness of beta-blocker therapy in vasovagal syncope.
    Kapoor JR
    J Am Coll Cardiol; 2008 Jun; 51(24):2372; author reply 2372-3. PubMed ID: 18549925
    [No Abstract]   [Full Text] [Related]  

  • 9. Meta-analysis of nonselective versus beta-1 adrenoceptor-selective blockade in prevention of tilt-induced neurocardiogenic syncope.
    Dendi R; Goldstein DS
    Am J Cardiol; 2002 Jun; 89(11):1319-21. PubMed ID: 12031740
    [No Abstract]   [Full Text] [Related]  

  • 10. The usefulness of tilt testing with an intravenous beta-blocker in assessing the efficacy of long-term therapy in patients with vasovagal syncope.
    Gielerak G; Makowski K; Dłuzniewska E; Stec A; Cholewa M
    Kardiol Pol; 2003 Aug; 59(8):93-104; commentary 103-4. PubMed ID: 14560324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of metoprolol versus conventional treatment in preventing recurrence of vasovagal syncope in children and adolescents.
    Zhang Q; Jin H; Wang L; Chen J; Tang C; Du J
    Med Sci Monit; 2008 Apr; 14(4):CR199-203. PubMed ID: 18376348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocardiogenic syncope: latest pharmacological therapies.
    Chen LY; Shen WK
    Expert Opin Pharmacother; 2006 Jun; 7(9):1151-62. PubMed ID: 16732702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Closed loop stimulation in prevention of vasovagal syncope. Inotropy Controlled Pacing in Vasovagal Syncope (INVASY): a multicentre randomized, single blind, controlled study.
    Occhetta E; Bortnik M; Audoglio R; Vassanelli C;
    Europace; 2004 Nov; 6(6):538-47. PubMed ID: 15519257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blockers no better than placebo in the treatment of vasovagal syncope.
    Phillips J; Krist A
    J Fam Pract; 2002 Nov; 51(11):921. PubMed ID: 12485542
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial).
    van Dijk N; Quartieri F; Blanc JJ; Garcia-Civera R; Brignole M; Moya A; Wieling W;
    J Am Coll Cardiol; 2006 Oct; 48(8):1652-7. PubMed ID: 17045903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Controversies in the conduction and evaluation of clinical trials results for the treatment in vasovagal syncope].
    Gajek J; Zyśko D; Halawa B
    Pol Merkur Lekarski; 2003 May; 14(83):464-7. PubMed ID: 12939829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blockers, hypertension, and randomized controlled trials: science and sensibility.
    Gupta VK
    J Am Coll Cardiol; 2009 Jun; 53(22):2102-3; author reply 2106-7. PubMed ID: 19477366
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results of midodrin treatment of vasovagal syncope].
    Kuchinskaia EA; Pevzner AV; Vershuta EV; Al'bitskaia KV; Kheĭmets GI; Rogoza AN; Golitsyn SP
    Ter Arkh; 2004; 76(8):38-41. PubMed ID: 15471395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasovagal syncope in children and adolescents.
    Kapusta R
    Gen Dent; 2008; 56(4):340-5. PubMed ID: 19284194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expectation effect and cardiac pacing for refractory vasovagal syncope.
    Sud S; Massel D; Klein GJ; Leong-Sit P; Yee R; Skanes AC; Gula LJ; Krahn AD
    Am J Med; 2007 Jan; 120(1):54-62. PubMed ID: 17208080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.